Feng Li

Dr. Feng Li


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2018 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
QWQing-Yun Wu
Qing-Yun Wu
YZYuan-Yuan Zhu
Yuan-Yuan Zhu
YLYang Liu
Yang Liu
FWFang Wei
Fang Wei
YTYu-Xue Tong
Yu-Xue Tong
KXKai-Lin Xu
Kai-Lin Xu
Downregulation of suppressor of cytokine signalling-1 (SOCS1) is one of the vital reasons for JAK1-STAT3 pathway activation in acute myeloid leukaemia (AML). CUE domain-containing 2 (CUEDC2) was a novel interacting partner of SOCS1 and a positive correlation between the expression of CUEDC2 and SOCS1 was confirmed in primary AML cells and AML cell lines without SOCS1 promoter methylation. We aimed to explore roles of CUEDC2 in regulating ubiquitin-mediated degradation of SOCS1 in the leukaemogenesis of AML.According to in vitro experiments, CUEDC2 overexpression increased the level of SOCS1 protein, suppressed JAK1-STAT3 pathway activation. The suppression of this pathway inhibited AML cells’ proliferation by causing G1 arrest and enhanced AML cells’ sensitivity to cytarabine and idarubicin. Similarity, downregulation of CUEDC2 produced opposite results. Knockout or low expression of CUEDC2 in mouse or AML patients displayed lower overall survival and event-free survival rates, compared with these mouse and AML patients had high-CUEDC2 expression. Mechanistic studies revealed that CUEDC2 overexpression attenuated SOCS1 ubiquitination, facilitated its stabilisation by enhancing SOCS1, Elongin C and Cullin-2 (CUL2) interactions, thus inhibited JAK1-STAT3 pathway and leukaemogenesis of AML. Therefore, our novel findings indicated that CUEDC2 interacted with SOCS1 to suppress SOCS1’s ubiquitin-mediated degradation, JAK1-STAT3 pathway activation and leukaemogenesis of AML.

1 July 2019 in Neuroscience Letters
Verified
Journal Article
Closed access
FLFeng Li
Feng Li
DJDan Jin
Dan Jin
LGLi Guan
Li Guan
CZCheng-Chen Zhang
Cheng-Chen Zhang
TWTing Wu
Ting Wu
DGDian-Shuai Gao
Dian-Shuai Gao

1 October 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
QWQing-Yun Wu
Qing-Yun Wu
MMMeng-Meng Ma
Meng-Meng Ma
YTYu-Xue Tong
Yu-Xue Tong
YZYuan-Yuan Zhu
Yuan-Yuan Zhu
YLYang Liu
Yang Liu
KXKailin Xu
Kailin Xu

16 August 2022 in Frontiers in Genetics
Verified
Journal Article
Open access
XMXing-Ru Mu
Xing-Ru Mu
MMMeng-Meng Ma
Meng-Meng Ma
ZLZi-Yi Lu
Zi-Yi Lu
JLJun Liu
Jun Liu
YXYu-Tong Xue
Yu-Tong Xue
QWQing-Yun Wu
Qing-Yun Wu
Polo-like kinase 4 (PLK4), a key regulator of centriole biogenesis, is frequently overexpressed in cancer cells. However, roles and the mechanism of PLK4 in the leukemiagenesis of acute myeloid leukemia (AML) remain unclear. In this study, the PLK4 inhibitor Centrinone and the shRNA knockdown were used to investigate roles and the mechanism of PLK4 in the leukemiagenesis of AML. Our results indicated that Centrinone inhibited the proliferation of AML cells in a dose- and time-dependent manner via reduced the expression of PLK4 both in the protein and mRNA levels. Moreover, colony formation assay revealed that Centrinone reduced the number and the size of the AML colonies. Centrinone induced AML cell apoptosis by increasing the activation of Caspase-3/poly ADP-ribose polymerase (PARP). Notably, Centrinone caused the G2/M phase cell cycle arrest by decreasing the expression of cell cycle-related proteins such as Cyclin A2, Cyclin B1, and Cyclin-dependent kinase 1 (CDK1). Consistent with above results, knockdown the expression of PLK4 also inhibited cell proliferation and colony formation, induced cell apoptosis, and caused G2/M phase cell cycle arrest without affecting cell differentiation. All in all, this study suggested that PLK4 inhibited the progression of AML in vitro, and these results herein may provide clues in roles of PLK4 in the leukemiagenesis of AML.

1 September 2018 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
QWQing-Yun Wu
Qing-Yun Wu
MMMeng-Meng Ma
Meng-Meng Ma
LFLin Fu
Lin Fu
YZYuan-Yuan Zhu
Yuan-Yuan Zhu
YLYang Liu
Yang Liu
KXKailin Xu
Kailin Xu